Anthropic has terminated discussions to acquire Israeli AI startup Decart in what would have been a $6 billion transaction, according to multiple reports. The deal collapse marks a significant pivot for the AI safety-focused company, which had been exploring the acquisition as part of broader expansion efforts. While specific reasons for the withdrawal weren't detailed in available reports, the move suggests Anthropic is reassessing its M&A strategy and may be prioritizing organic development over external acquisitions at this stage of its growth.
The timing of the deal's collapse carries implications for Anthropic's capital deployment strategy. The company, which has raised substantial funding and is reportedly preparing for eventual public markets, appears to be exercising fiscal discipline by avoiding a multi-billion-dollar acquisition. This conservative approach aligns with industry trends where AI companies are increasingly scrutinizing acquisition economics and focusing resources on core product development, particularly around Claude and developer tools that form Anthropic's competitive moat.
Inside Anthropic Labs, the company maintains a lean 20-person experimental team operating under an unconventional structure that permits 80% idea failure rates and conducts biweekly retention reviews. This high-velocity, risk-tolerant approach to innovation suggests Anthropic is betting on internal breakthroughs rather than external talent acquisition. The Decart deal's abandonment reinforces that Anthropic's growth strategy centers on Claude model improvements, Constitutional AI research, and developer platform expansion—areas where the company believes it can achieve differentiation without acquisition-driven scale.
The decision reflects broader strategic choices at Anthropic as it positions itself for potential public markets and sustained competition in the generative AI landscape.